Category: image manipulation

Cancer researcher under investigation in Italy notches eighth retraction

ejcancerAlfredo Fusco, the researcher in Italy who is under criminal investigation and has had seven papers retracted, has lost yet another study.

The investigation, which came to light in late 2013, had focused on eight papers thought to demonstrate evidence of image manipulation.

The latest paper, in the European Journal of Cancer, studied mice with a genetic alteration associated with lipomas (benign fatty growths) in humans.

Here’s part of the notice for “Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice”: Continue reading Cancer researcher under investigation in Italy notches eighth retraction

Other shoe drops for MIT cancer researcher Robert Weinberg as Cell retraction appears

cell cloningRobert Weinberg, a prominent cancer scientist whose papers often notch hundreds or thousands of citations, has lost a fourth paper, this time a 2009 publication in Cell.

Journal Genes and Development pulled two of Weinberg’s papers in March, stating that they had retracted the 2009 study because data from several experiments was used in figures that seemed to represent only one. The Genes and Development papers were sunk because the “same analytical methodology was used.”

At the time, the Cell retraction was unavailable, though a spokesperson informed us it was forthcoming. The paper has been cited 482 times, according to Thomson Scientific’s Web of Knowledge.

Now that the notice has landed, here’s why the paper is being retracted: Continue reading Other shoe drops for MIT cancer researcher Robert Weinberg as Cell retraction appears

Cancer Cell issues big correction over “incorrectly cropped” figures, other issues

cancer cell A 2014 Cancer Cell paper became the subject of an erratum in January 2015, shortly after PubPeer members began criticizing the data. However, many issues brought up by commenters weren’t addressed in the correction notice, including a figure that might be two experiments spliced together to look like one.

The paper, led by Guido Franzoso at Imperial College London, claims that a new cancer drug called DTP3 kills myeloma cells “without causing any toxic side effects,” according to a press release from the school. Guido Franzoso is the founder of Kesios Therapeutics, a drug company which is set to begin clinical trials on DTP3.

The correction indicates that Western blots were cropped badly, which omitted several panels discussed in the text, while an “extra time point” was included accidentally. An antibody was also omitted from the description of the procedure.

PubPeer commenters have noticed additional issues, such as a criticism of figure 3D, which were not included or changed in this correction.

Here’s the correction for “Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors”: Continue reading Cancer Cell issues big correction over “incorrectly cropped” figures, other issues

Drug paper gets a fix, notching several corrections

rsc_tb_1_3_COVER.inddThe Journal of Materials Chemistry B has issued a laundry list of corrections for a 2014 chemotherapy paper, which address re-use of “some text”, incorrectly stated doses, and miscalculations of the drug concentration, among other issues.

The paper described a new way to deliver gemcitabine via nanoparticles, focusing the drug on the tumors.

It turns out the authors’ focus wasn’t so clear when writing the paper. The researchers, at the Chinese Academy of Medical Science, Peking Union Medical College, and Tianjin University in China, said they used “some text” from two 2013 papers by a team of French oncologists “without appropriate attribution,” as well as repeatedly getting the in vivo dose wrong. The manuscript also contained several incorrect calculations of the “drug loading,” or the proportion of active drug.

Here’s the correction for “Tailor-made gemcitabine prodrug nanoparticles from well-defined drug–polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapy” (free, but requires sign-in): Continue reading Drug paper gets a fix, notching several corrections

Nothing gold can stay: gold nanoparticle paper retracted for figure theft

matresexpA paper on gold nanoparticles has been retracted after the publisher learned one of the figures had a “high degree of similarity” to a figure published by other authors a few months prior.

According to the notice, it was two authors of the retracted paper themselves who pointed out the overlap. The first author, Pratap Sahoo, is not mentioned, although it does say all three authors agreed to retract. The corresponding author of the original paper told us he was unaware of the incident.

You can compare the figures for yourself – on the left is figure 6(a) from the retracted Materials Research Express paper, rotated 90 degrees. On the right is figure 4(e) from “Porous Au Nanoparticles with Tunable Plasmon Resonances and Intense Field Enhancements for Single-Particle SERS,” published in the Journal of Physical Chemistry Letters: Continue reading Nothing gold can stay: gold nanoparticle paper retracted for figure theft

“Not faithful” figures kill apoptosis paper

iaicoverA paper on apoptosis in mice has been retracted by Infection and Immunity after a reader tipped them off that several figures were “not faithful representations of the original data.”

When the journal, published by the American Society for Microbiology (ASM), contacted the authors at Anhui Medical University in Hefei, China, they claimed they couldn’t provide the experimental data thanks to “damage to a personal computer,” said Ferric Fang, editor of the journal and a member of the board of directors of the Center for Scientific Integrity, Retraction Watch’s parent organization. Seven figures in total were compromised, including several that were duplicated throughout the article.

Here’s the notice for “Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP, and the JNK Pathway in Toxoplasma gondii Infection in Mice”: Continue reading “Not faithful” figures kill apoptosis paper

Authors retract PNAS Epstein-Barr virus paper for “anomalous and duplicated” figures

pnas 2515PNAS has retracted a paper on the cancer-causing Epstein-Barr virus just two months after publication, in a notice that fingers a now-former graduate student for manipulating figures.

The paper tries to explain how Epstein-Barr virus blocks the immune system’s attempts to destroy it. According to the notice, the three “nonexperimentalist authors” – identified in the paper as two P.I.’s from University of Texas at Austin and one from the University of California, San Francisco – didn’t know the figures “were not reflective of original Northern blot and immunoblot data.”

That leaves UT Austin PhD student Jennifer Cox under the bus. Her LinkedIn says she pursued a PhD from 2010-2015, though it’s unclear if she’s received a degree. Cox’s name is at the top of P.I. Christopher Sullivan’s list of past lab members, and she’s the only one on the page whose name doesn’t hyperlink to additional information, such as a contact.

The school issued a press release about the study that quoted Cox, which has been removed from the UT site but is still available on Science Daily: Continue reading Authors retract PNAS Epstein-Barr virus paper for “anomalous and duplicated” figures

Two more retractions appear for prominent MIT cancer researcher Robert Weinberg

genes and developmentTwo identical retraction notices have popped up for MIT professor Robert Weinberg, a highly-cited cancer researcher who had a retraction and a correction in 2013, both in Cancer Cell. 

These two new retractions, in Genes and Development, stem directly from another paper by Weinberg and colleagues in Cell that will apparently be retracted, as the “same analytical methodology was used,” according to the notices [see bottom of the post for an update].

Weinberg is highly regarded, and at least 20 of his papers have been cited over a thousand times.

First author Scott Valastyan was a promising postdoc at the time of the paper’s publication. He was a 2011 Runyon Fellow at Harvard, a three-year, $156,000 award for outstanding cancer postdocs. He doesn’t seem to have published anything since 2012, though he is listed as a joint inventor with Weinberg on patents filed in 2009 and 2014.

Here are the notices for “Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis” (cited 73 times, according to Thomson Scientific’s Web of Knowledge) and “Activation of miR-31 function in already-established metastases elicits metastatic regression” (cited 54 times), both paywalled: Continue reading Two more retractions appear for prominent MIT cancer researcher Robert Weinberg

Second cell bio retraction from UPitt investigation of tweaked images

Journal of Cellular Physiology: Volume 229, Number 10, October 2Two researchers, Tong Wu and Chang Han, have lost a second paper as the result of a University of Pittsburgh investigation into image manipulations.

The first retraction, in Journal of Cellular Biochemistry, went live in February. The researchers, currently based at Tulane University, were originally tapped by pseudonymous tipster Juuichi Jigen, who created a website in 2012 to chronicle the allegations.

The blog lists six papers by the pair with supposedly questionable figures. According to Jigen, this latest retraction, in the Journal of Cellular Physiology, contains a figure (2A) that appears to reuse data from another paper, and another figure (3) where the data appear to be manipulated.

Continue reading Second cell bio retraction from UPitt investigation of tweaked images

Sun sets on Sun Yat-sen University cell bio paper

j cell scienceResearchers at Sun Yat-sen University in China have lost a paper in the Journal of Cell Science for “inappropriate figure manipulations,” which they blame entirely on the first author.

According to the notice, three figures were “inappropriately modified” — cells or nuclei were moved, and the edges of cell images were trimmed. The researchers place the responsibility on first author Liping Chen, claiming that “her co-authors were completely unaware.”

The modifications didn’t affect the conclusions, the note says, but after an investigation by Sun Yat-sen University, the journal decided to retract the paper. Liping Chen says she “regrets the inappropriate figure manipulations,” according to the note.

Continue reading Sun sets on Sun Yat-sen University cell bio paper